NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · MID CAP
Outset Medical, Inc. OM
8 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$119.5M
▲ 5.1% vs FY2024
EPS · FY25
$-5.37
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-106.2%
Net margin · FY25
-68.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 119.5M
Revenue, FY2025 · full 8-year series below
Revenue
Net income
The company lost 68 cents on every revenue dollar this year.
Per share
USD -5.37
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-106.2%
Return on equity, FY2025
ROE
Operating margin-55.8%
Net margin-68.3%
Return on assets-30.2%
Each USD of equity lost 106 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+19.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+1.2%
+19.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.02B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 264.5M
total assets, end of FY2025
Total assetsUSD 264.5M
EquityUSD 127.0M
CashUSD 35.0M
Gross debtUSD 96.2M
Net debtUSD 61.2M
Current ratio6.67×
Net debt stands at 48% of equity.
History
8 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
Revenue $B
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
Operating income $B
−0.1
−0.1
−0.2
−0.2
−0.1
−0.1
−0.1
−0.0
EBITDA $B
−0.1
−0.1
−0.2
−0.2
−0.1
−0.1
−0.1
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.1
−0.1
−0.2
−0.2
−0.1
−0.1
−0.1
−0.0
EPS, diluted $
−5.37
−36.96
−52.28
−3.38
−2.89
−4.85
−99.58
−100.75
Dividend / sh $
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
ROE %
−106.2
−171.0
−93.7
−52.6
−37.6
·
·
·
Shares out B
0.02
0.00
0.05
0.05
0.05
0.04
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
27 of 30
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 3 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed